Business Context and Reporting Period
Company: NeOnc Technologies Holdings, Inc. (NTHI)
Filing Type: Form 8-K (Current Report)
Date of Report: August 12, 2026
Reporting Period: Event date August 12, 2026
Business Context: The Company is an emerging growth company incorporated in Delaware, trading on The Nasdaq Stock Market LLC. This filing serves as a Regulation FD disclosure regarding a specific clinical trial update.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain audited or unaudited financial statements.
Material Changes
Clinical Development Update: The Company hosted an investor conference call on August 12, 2026, to discuss results from the Phase 2a portion of the NEO100-01 clinical trial. A transcript of this call is furnished as Exhibit 99.1.
Guidance, Outlook, and Risks
Management Commentary: The primary focus of the filing is the dissemination of Phase 2a results for NEO100-01 via the investor conference call transcript.
Legal Disclaimer: The information contained in Item 7.01 and Exhibit 99.1 is furnished, not "filed," for purposes of Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section and is not incorporated by reference into other filings unless expressly stated.
Risks: No specific risk factors or contingencies are detailed in the text of this 8-K summary; investors are directed to the conference call transcript for detailed discussion.
Investor Verification Checklist
- Review Exhibit 99.1 (Transcript of the August 12, 2026 investor conference call) for specific data points regarding the Phase 2a results of NEO100-01.
- Verify the clinical trial status and any subsequent regulatory filings related to the NEO100-01 program.
- Confirm the Company's emerging growth company status and its implications for financial reporting standards.
- Check for any future filings that may incorporate the conference call information by reference.